Don’t miss this: webinar on the WHO EML 2025 update

Don’t miss this: webinar on the WHO EML 2025 update

The World Federation of Hemophilia (WFH) is pleased to invite representatives from its national member organizations (NMOs), national governments, healthcare providers, industry partners, other patient advocacy and scientific organizations from the global bleeding disorders community to an informational webinar on the recent milestone revisions to the World Health Organization (WHO) Essential Medicines List (EML).

Also available in: Français Español

A concerted effort by the WFH and its partners has led to the WHO updating its EML and the Essential Medicines List for Children (EMLc) to better align the EMLs to the international clinical guidelines for the management of hemophilia and von Willebrand Disease (VWD). The webinar “WHO Essential Medicines List 2025 Update: Impact on Bleeding Disorders Community” will show how these revisions can be leveraged to have a positive impact on lives of people with bleeding disorders everywhere.

The objectives of the webinar are to provide information on these critical changes that have been made to WHO EMLs, the advocacy carried out by the WFH in collaboration with key partners and stakeholders from the bleeding disorders community, and what the changes mean in practice for our community. During the webinar, participants will hear from Cesar Garrido, WFH President; Glenn Pierce, MD, PhD, WFH Vice President, Medical; and Brian O’Mahony, Chief Executive, Irish Haemophilia Society. A Q&A session will follow the talks.

Register today to find out more about this milestone accomplishment and how you can get involved in leveraging the WHO EML to make a difference in the lives of people with bleeding disorders in your country.

To read the article, “WFH mobilizes global community to achieve milestone revisions to WHO EML” on the WFH News page, click here. To view the recently-published 24th Essential Medicines List and the 10th Essential Medicines List for Children of the World Health Organization (WHO), please click here.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.